Pharmacological treatment options for cryopyrin-associated periodic syndromes.

Abstract excerpt

INTRODUCTION: Cryopyrin-associated periodic syndromes (CAPS) are rare monogenic autoinflammatory diseases, comprising a spectrum of phenotypes of varying severity. CAPS are associated with gain-of-function mutations in the NLRP3 inflammasome, a multiprotein complex critical for the activation of IL-1ß, and are characterized by episodes of fever, urticaria-like rash, musculoskeletal, ocular, and neurological...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antibodies, Monoclonal
• Share to Antibodies, Monoclonal, Humanized
• Share to Cryopyrin-Associated Periodic Syndromes
• Share to Interleukin 1 Receptor Antagonist Protein